Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
First, the patient has type 2 diabetes with comorbid obesity and needs more aggressive weight reduction than dulaglutide delivers
Pancreatitis risk: Patients with a history of pancreatitis should be monitored carefully, as incretin-based therapies have been associated with rare pancreatic events
However, these patients often have severe comorbidities, altered nutritional status, and multiple medication interactions that complicate tirzepatide use
Many who are on GLP-1'S are also changing their eating habits with the help of dietitians...it's not an 'either/or' proposition
US$ 28.27
US$ 26.27
US$ 26.46
US$ 24.95
US$ 28.23
